Zobrazeno 1 - 10
of 26 166
pro vyhledávání: '"Bridged Bicyclo Compounds"'
Autor:
Alaei S; AbbVie, Inc., Chicago, Illinois., Wang Y; AbbVie, Inc., Chicago, Illinois., Liu Y; AbbVie, Inc., Chicago, Illinois., Schiele J; AbbVie, Inc., Chicago, Illinois., Deng R; Genentech Inc., South San Francisco, California., Shiller D; AbbVie, Inc., Chicago, Illinois., Marroum P; AbbVie, Inc., Chicago, Illinois., Menon R; AbbVie, Inc., Chicago, Illinois., Salem AH; Ain Shams University, Cairo, Egypt. Electronic address: ahmed.salem@abbvie.com.
Publikováno v:
Clinical therapeutics [Clin Ther] 2024 Oct; Vol. 46 (10), pp. 752-758. Date of Electronic Publication: 2024 May 22.
Autor:
Russo D; Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy. Electronic address: domenico.russo@unibs.it., Polverelli N; Department of Molecular Medicine, Division of Hematology, Fondazione IRCCS Policlinico San Matteo, University of Pavia, Pavia, Italy., Bernardi S; Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy; Centro di Ricerca Emato-Oncologica AIL, ASST Spedali Civili di Brescia, Brescia, Italy; National Center for Gene Therapy and Drug based on RNA Technology, Padova, Italy., Santarone S; Centro Trapianti Midollo Osseo, Azienda Sanitaria Locale di Pescara, Pescara, Italy., Farina M; Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy., Borlenghi E; Division of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy., Onida F; MTN Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, ASST Fatebenefratelli-Sacco, University of Milan, Milan, Italy., Castagna L; Bone Marrow Transplantation Unit, Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy., Bramanti S; Humanitas Clinical and Research Center, IRCCS, Rozzano, Italy., Carella AM; IRCCS Ospedale Casa Sollievo della Sofferenza, Foggia, Italy., Sorasio R; Department of Hematology, S Croce e Carle Hospital, Cuneo, Italy., Martino M; Centro Unico Trapianti, Division of Hematology, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy., Alati C; Centro Unico Trapianti, Division of Hematology, Grande Ospedale Metropolitano Bianchi Melacrino Morelli, Reggio Calabria, Italy., Olivieri A; Clinica di Ematologia Azienda Ospedaliero Universitaria delle Marche, Ancona, Italy., Beltrami G; UO Ematologia e Terapie Cellulari, IRCCS Azienda Ospedaliera Universitaria San Martino, Genova, Italy., Curti A; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia Seràgnoli, Bologna, Italy., Vetro C; Division of Hematology, BMT Unit, AOU Policlinico G Rodolico S Marco, Catania, Italy., Leotta S; Division of Hematology, BMT Unit, AOU Policlinico G Rodolico S Marco, Catania, Italy., Mancini V; Department of Hematology, ASST Grande Ospedale Metropolitano Niguarda, Milan, Italy., Terruzzi E; Department of Hematology, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy., Bernardi M; Unit of Hematology and Bone Marrow Transplantation, IRCCS Ospedale San Raffaele, Milan, Italy., Galieni P; UOC Hematology, Mazzoni Hospital Ascoli Piceno, Ascoli Piceno, Italy., Musto P; UOC Ematologia, Bari, Italy., Cerretti R; Department of Hematology, Stem Cell Transplant Unit, Policlinico Tor Vergata, Rome, Italy., Giaccone L; Univesity of Torino, AOU Città Della Salute E Della Scienza Di Torino, Torino, Italy., Skert C; Unit of Haematology and Bone Marrow Transplantation, Ospedale Dell'Angelo, Venezia Mestre, Italy., Radici V; Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy., Vezzoli M; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Calza S; Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy., Leoni A; Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy; Centro di Ricerca Emato-Oncologica AIL, ASST Spedali Civili di Brescia, Brescia, Italy., Garuffo L; Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy; Centro di Ricerca Emato-Oncologica AIL, ASST Spedali Civili di Brescia, Brescia, Italy., Bonvicini C; Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni Di Dio Fatebenefratelli, Brescia, Italy., Pellizzeri S; Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy., Malagola M; Department of Clinical and Experimental Science, University of Brescia, ASST Spedali Civili di Brescia, Brescia, Italy., Ciceri F; Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan, Italy.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Nov; Vol. 11 (11), pp. e830-e838. Date of Electronic Publication: 2024 Sep 20.
Autor:
Short NJ; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. Electronic address: nshort@mdanderson.org., Nguyen D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Jabbour E; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Senapati J; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Zeng Z; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Issa GC; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Abbas H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nasnas C; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Qiao W; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huang X; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Borthakur G; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Chien K; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Haddad FG; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Pemmaraju N; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Karrar OS; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Nguyen D; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Konopleva M; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA; Department of Oncology, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY, USA., Kantarjian H; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Ravandi F; Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Publikováno v:
The Lancet. Haematology [Lancet Haematol] 2024 Nov; Vol. 11 (11), pp. e839-e849. Date of Electronic Publication: 2024 Sep 17.
Autor:
Qureshi Z; Department of Medicine, The Frank H. Netter MD School of Medicine at Quinnipiac University, Bridgeport, CT. Electronic address: zaheerqureshimd@gmail.com., Altaf F; Department of Internal Medicine, Icahn School of Medicine at Mount Sinai/BronxCare Health System, New York, NY., Jamil A; Department of Medicine, Samaritan Medical Centre Watertown, Watertown, NY., Siddique R; Independent Research Associate, Watertown, NY.
Publikováno v:
Clinical lymphoma, myeloma & leukemia [Clin Lymphoma Myeloma Leuk] 2024 Nov; Vol. 24 (11), pp. e835-e851. Date of Electronic Publication: 2024 Aug 03.
Autor:
Gibson A; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Dickson S; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., McCall D; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Garcia M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Connors J; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., He J; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Roth M; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nunez C; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Cuglievan B; Department of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
Pediatric blood & cancer [Pediatr Blood Cancer] 2024 Nov; Vol. 71 (11), pp. e31286. Date of Electronic Publication: 2024 Aug 16.
Autor:
Acker F; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany., Chromik J; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany., Tiedjen E; Carreras Leukemia Center, Hematology, Oncology, Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Marburg, Germany., Wolf S; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, A Partnership Between DKFZ and University Hospital Frankfurt, Frankfurt am Main, Germany., Vischedyk JB; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.; University Cancer Center Frankfurt (UCT), Goethe University Frankfurt, University Hospital, Frankfurt, Germany., Makowka P; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany., Enßle JC; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, A Partnership Between DKFZ and University Hospital Frankfurt, Frankfurt am Main, Germany., Kouidri K; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany., Sebastian M; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany., Steffen B; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany., Oellerich T; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, A Partnership Between DKFZ and University Hospital Frankfurt, Frankfurt am Main, Germany., Serve H; Department of Medicine II, Hematology and Oncology, Goethe University Frankfurt, University Hospital, Frankfurt, Germany.; Frankfurt Cancer Institute (FCI), Frankfurt am Main, Germany.; German Cancer Consortium (DKTK), Partner Site Frankfurt/Mainz, A Partnership Between DKFZ and University Hospital Frankfurt, Frankfurt am Main, Germany., Neubauer A; Carreras Leukemia Center, Hematology, Oncology, Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Marburg, Germany., Schäfer JA; Carreras Leukemia Center, Hematology, Oncology, Immunology, Philipps University Marburg, and University Hospital Giessen and Marburg, Marburg, Germany., Bittenbring JT; Department of Internal Medicine 1, Oncology, Hematology, Clinical Immunology and Rheumatology, Saarland University Medical Center, Homburg, Germany.
Publikováno v:
European journal of haematology [Eur J Haematol] 2024 Nov; Vol. 113 (5), pp. 623-630. Date of Electronic Publication: 2024 Jul 18.
Autor:
Ito T; Department of Hematology, Kansai Medical University Hospital, 2-3-1 Shinmachi, Hirakata City, Osaka, Japan. itot@hirakata.kmu.ac.jp., Kamimura T; Department of Hematology, Harasanshin Hospital, Fukuoka, Japan., Kiguchi T; Department of Diabetes, Endocrinology and Hematology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan., Kato K; Department of Hematology, Oncology and Cardiovascular Medicine, Kyushu University Hospital, Fukuoka, Japan., Takenaka R; AbbVie GK, Tokyo, Japan., Kobayashi M; AbbVie GK, Tokyo, Japan., Ito A; AbbVie GK, Tokyo, Japan., Sakai M; AbbVie GK, Tokyo, Japan., Izutsu K; Department of Hematology, National Cancer Center Hospital, Tokyo, Japan.
Publikováno v:
International journal of hematology [Int J Hematol] 2024 Nov; Vol. 120 (5), pp. 613-620. Date of Electronic Publication: 2024 Aug 21.
Autor:
Al-Sawaf O; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Robrecht S; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Zhang C; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Olivieri S; F. Hoffmann-La Roche Ltd, Basel, Switzerland., Chang YM; F. Hoffmann-La Roche Ltd, Mississauga, ON, Canada., Fink AM; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Tausch E; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Schneider C; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Ritgen M; Universitätsklinikum Schleswig Holstein, Kiel, Germany., Kreuzer KA; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Sivchev L; Multiprofile Hospital for Active Treatment Pazardjik, Pazardzhik, Bulgaria., Niemann CU; Rigshospitalet, Copenhagen, Denmark., Schwarer A; Box Hill Hospital, Box Hill, VIC, Australia., Loscertales J; Hospital De La Princesa, Madrid, Spain., Weinkove R; Te Rerenga Ora Wellington Blood and Cancer Centre, Te Whatu Ora Health New Zealand Capital, Wellington, New Zealand.; Cancer Immunotherapy Program, Malaghan Institute of Medical Research, Wellington, New Zealand., Strumberg D; Evangelisches Krankenhaus Herne, Herne, Germany., Kilfoyle A; Palmerston North Hospital, Palmerston North, New Zealand., Manzoor BS; AbbVie Inc, Chicago, IL., Jawaid D; AbbVie Inc, Chicago, IL., Emechebe N; AbbVie Inc, Chicago, IL., Devine J; Genentech Inc, South San Francisco, CA., Boyer M; F. Hoffmann-La Roche Ltd, Welwyn, United Kingdom., Runkel ED; AbbVie Inc, Chicago, IL., Eichhorst B; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Stilgenbauer S; Division of CLL, Department III of Internal Medicine, University Hospital Ulm, Ulm, Germany., Jiang Y; Genentech Inc, South San Francisco, CA., Hallek M; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany., Fischer K; Department I of Internal Medicine, Faculty of Medicine and University Hospital of Cologne, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, German Chronic Lymphocytic Leukemia Study Group, University of Cologne, Cologne, Germany.
Publikováno v:
Blood [Blood] 2024 Oct 31; Vol. 144 (18), pp. 1924-1935.
Autor:
Wegmann R; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland., Bonilla X; Department of Computer Science, ETH Zurich, Zurich, Switzerland., Casanova R; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland., Chevrier S; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland., Coelho R; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland., Esposito C; Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland., Ficek-Pascual J; Department of Computer Science, ETH Zurich, Zurich, Switzerland., Goetze S; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.; ETH PHRT Swiss Multi-Omics Center (SMOC), Lausanne, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Gut G; Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland., Jacob F; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland., Jacobs A; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland., Kuipers J; Department of Biosystems Science and Engineering, ETH Zurich, Zurich, Switzerland., Lischetti U; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland., Mena J; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland., Milani ES; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland., Prummer M; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; NEXUS Personalized Health Technologies, ETH Zurich, Zurich, Switzerland., Del Castillo JS; Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland., Singer F; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; NEXUS Personalized Health Technologies, ETH Zurich, Zurich, Switzerland., Sivapatham S; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland., Toussaint NC; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; NEXUS Personalized Health Technologies, ETH Zurich, Zurich, Switzerland.; Swiss Data Science Center, ETH Zürich, Zurich, Switzerland., Vilinovszki O; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Wildschut MHE; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland.; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland.; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Thavayogarajah T; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland., Malani D; Harvard Medical School and Dana-Farber Cancer Institute, Boston, USA., Aebersold R; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland., Bacac M; Roche Pharmaceutical Research and Early Development, Roche Innovation Center Zurich, Zurich, Switzerland., Beerenwinkel N; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; Department of Biosystems Science and Engineering, ETH Zurich, Zurich, Switzerland., Beisel C; Department of Biosystems Science and Engineering, ETH Zurich, Zurich, Switzerland., Bodenmiller B; Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland., Heinzelmann-Schwarz V; Department of Biomedicine, University Hospital Basel and University of Basel, Basel, Switzerland., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.; University of Zurich, Faculty of Medicine, Zurich, Switzerland., Levesque MP; Department of Dermatology, University Hospital Zurich, Zurich, Switzerland., Moch H; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland.; University of Zurich, Faculty of Medicine, Zurich, Switzerland., Pelkmans L; Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland., Rätsch G; Department of Computer Science, ETH Zurich, Zurich, Switzerland.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland.; AI Center at ETH Zurich, Zurich, Switzerland., Tolnay M; Institute of Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland., Wicki A; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland.; University of Zurich, Faculty of Medicine, Zurich, Switzerland., Wollscheid B; Department of Health Sciences and Technology, ETH Zurich, Zurich, Switzerland., Manz MG; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland. markus.manz@usz.ch., Snijder B; Institute of Molecular Systems Biology, Department of Biology, ETH Zurich, Zurich, Switzerland. snijder@imsb.biol.ethz.ch.; SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland. snijder@imsb.biol.ethz.ch., Theocharides APA; Department of Medical Oncology and Hematology, University Hospital Zurich, Zurich, Switzerland. alexandre.theocharides@usz.ch.
Publikováno v:
Nature communications [Nat Commun] 2024 Oct 30; Vol. 15 (1), pp. 9402. Date of Electronic Publication: 2024 Oct 30.
Autor:
Gharia AA; Electrical Engineering Division, Department of Engineering, University of Cambridge, Cambridge, UK.; Laboratory of Immune System Biology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA., Bradfield CJ; Laboratory of Immune System Biology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA., Jenkins EPW; Electrical Engineering Division, Department of Engineering, University of Cambridge, Cambridge, UK., Fraser IDC; Laboratory of Immune System Biology, National Institute of Allergy and Infectious Disease, National Institutes of Health, Bethesda, MD, USA., Malliaras GG; Electrical Engineering Division, Department of Engineering, University of Cambridge, Cambridge, UK.
Publikováno v:
Science advances [Sci Adv] 2024 Oct 25; Vol. 10 (43), pp. eado5042. Date of Electronic Publication: 2024 Oct 25.